Predict your next investment

Angel Investor (Individual)

See what CB Insights has to offer

Investments

15

About Jochen Engert

Jochen Engert Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Jochen Engert News

Vorwerk Ventures, Acton Capital and Picus invest €7M in MedKitDoc

Jan 6, 2022

MedKitDoc, a German telemedicine platform, raises €7m in seed financing. In addition to Vorwerk Ventures, Acton Capital, and existing investor Picus Capital, FlixBus founders Daniel Krauss and Jochen Engert are […] The post Vorwerk Ventures, Acton Capital and Picus invest €7M in MedKitDoc appeared first on Business Leader.

Jochen Engert Investments

15 Investments

Jochen Engert has made 15 investments. Their latest investment was in Medkitdoc as part of their Seed VC on December 12, 2021.

CBI Logo

Jochen Engert Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/28/2021

Seed VC

Medkitdoc

$7.92M

Yes

8

6/24/2021

Seed VC

Truckoo

Yes

1

5/5/2021

Series A

Metals Hub

$11M

No

3

3/12/2021

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

3/31/2020

Seed VC - III

Subscribe to see more

Subscribe to see more

10

Date

12/28/2021

6/24/2021

5/5/2021

3/12/2021

3/31/2020

Round

Seed VC

Seed VC

Series A

Seed VC

Seed VC - III

Company

Medkitdoc

Truckoo

Metals Hub

Subscribe to see more

Subscribe to see more

Amount

$7.92M

$11M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

8

1

3

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.